Clinical Trials - TEVA

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07197866An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyNOT_YET_RECRUITINGPHASE22025-09-292029-05-172029-05-03
NCT06807463A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseRECRUITINGPHASE22025-03-312027-09-142026-09-15
NCT06911567A Study to Assess New Formulations of TEV-56286COMPLETEDPHASE12025-03-102025-06-022025-06-02
NCT06742957Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque PsoriasisACTIVE_NOT_RECRUITINGPHASE32024-12-172025-11-282025-10-31
NCT06664619A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaRECRUITINGPHASE32024-12-122026-05-312026-05-31
NCT06625177A Trial to Test the Safety and Efficacy of TEV-53408 in Treating VitiligoRECRUITINGPHASE12024-11-112027-06-052026-05-09
NCT06627231Mass Balance Clinical Trial With TEV-56286COMPLETEDPHASE12024-10-082024-11-292024-11-29
NCT06568237A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy StudyRECRUITINGPHASE22024-10-022027-06-172027-05-20
NCT06480552An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsRECRUITINGPHASE12024-07-222031-02-252029-05-26
NCT06290102Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldCOMPLETEDPHASE12024-05-162024-10-072024-10-01
NCT06253546Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaCOMPLETEDPHASE12024-03-282025-06-122025-06-12
NCT06319170Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderCOMPLETEDPHASE12024-03-282025-01-152025-01-15
NCT06315283An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With SchizophreniaCOMPLETEDPHASE12024-03-202025-09-042025-08-14
NCT06052267A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsRECRUITINGPHASE32023-08-302026-07-172026-07-17
NCT05693935A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaCOMPLETEDPHASE32023-01-242025-01-272024-03-19
NCT05668013A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE22023-01-112031-03-082025-12-20
NCT05617820Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal AtrophyCOMPLETEDPHASE32022-11-152024-03-152024-03-15
NCT05458011A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With MigraineCOMPLETEDPHASE32022-09-302024-06-132024-01-31
NCT05550337Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne VulgarisCOMPLETEDPHASE32022-09-192023-05-092023-05-09
NCT05499130A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseCOMPLETEDPHASE22022-08-292024-11-122024-11-12
NCT04976192Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaCOMPLETEDPHASE32021-08-302024-04-052024-04-05
NCT04847674A Study to Test if TEV-53275 is Effective in Relieving AsthmaTERMINATEDPHASE22021-05-042022-04-282022-04-28
NCT04729621A Study to Test if TVB-009P is Effective in Relieving Postmenopausal OsteoporosisCOMPLETEDPHASE32021-03-222023-06-192022-12-31
NCT04677959A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaCOMPLETEDPHASE42021-02-162022-03-102022-03-04
NCT04682353A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive AgeCOMPLETEDPHASE12020-12-142023-01-122022-07-11
NCT03890666A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With AsthmaCOMPLETEDPHASE42020-10-262021-10-042021-10-04
NCT04447729A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain SyndromeWITHDRAWNPHASE22020-10-152022-02-102022-02-10
NCT04545385A Study to Test if TEV-48574 is Effective in Relieving AsthmaTERMINATEDPHASE22020-10-072022-01-172022-01-17
NCT04530110A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsACTIVE_NOT_RECRUITINGPHASE32020-09-162025-12-312025-08-15
NCT04464707A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeCOMPLETEDPHASE32020-07-302024-11-292024-11-29
NCT04458857A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgeCOMPLETEDPHASE32020-07-152024-03-132024-03-13
NCT04200352A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral PalsyTERMINATEDPHASE32020-02-042023-02-142023-02-14
NCT04088266An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.WITHDRAWNPHASE42020-012020-122020-12
NCT04041284A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderCOMPLETEDPHASE42019-09-132022-08-312022-08-31
NCT03813238A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and AdolescentsCOMPLETEDPHASE32019-08-062022-07-212022-07-05
NCT03965091A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With FibromyalgiaTERMINATEDPHASE22019-07-312022-01-192022-01-19
NCT03893825A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaCOMPLETEDPHASE32019-04-172021-12-022021-12-02
NCT03954444A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"COMPLETEDPHASE32019-04-152020-02-272020-01-07
NCT03879837Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcgCOMPLETEDPHASE32019-03-252021-07-092021-05-28
NCT03700658A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046COMPLETEDPHASE12019-01-152020-10-022020-10-02
NCT03756883Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With AsthmaCOMPLETEDPHASE32018-12-032019-11-102019-10-26
NCT03571256A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)COMPLETEDPHASE32018-05-312019-12-092019-12-09
NCT03567291Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and AdolescentsTERMINATEDPHASE32018-05-252020-05-152020-05-15
NCT03503318Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaCOMPLETEDPHASE32018-04-272020-12-032020-09-30
NCT03499873Clinical Endpoint Study of Nepafenac 0.3% Opthalmic SuspensionCOMPLETEDPHASE32018-03-282018-12-182018-10-31
NCT03452943Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and AdolescentsCOMPLETEDPHASE2, PHASE32018-02-052019-11-122019-11-12
NCT03347188A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)COMPLETEDPHASE22017-12-182020-06-032020-03-13
NCT03308968An Efficacy and Safety Study of Fremanezumab in Adults With MigraineCOMPLETEDPHASE32017-10-132019-05-292018-10-02
NCT03301649Clinical Endpoint Study of Ivermectin 0.5% LotionCOMPLETEDPHASE32017-10-072018-03-122018-03-12
NCT03256695Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32017-09-282018-04-172018-04-17
NCT03029000Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy ParticipantsTERMINATEDPHASE32017-08-022017-10-302017-10-30
NCT02937168An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway InflammationTERMINATEDPHASE42017-05-082017-05-242017-05-24
NCT03107052A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster HeadacheTERMINATEDPHASE32017-04-272019-06-112019-06-11
NCT03052725A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaTERMINATEDPHASE32017-03-102018-02-222018-02-22
NCT02969408A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With AsthmaCOMPLETEDPHASE32017-02-132018-02-022018-02-02
NCT02945046A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)TERMINATEDPHASE32017-01-192019-05-132019-05-13
NCT02964338A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)TERMINATEDPHASE32017-01-172018-07-182018-07-18
NCT02495168Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic ParticipantsCOMPLETEDPHASE32017-01-132018-05-312018-05-31
NCT02980133Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerCOMPLETEDPHASE32016-12-282019-04-132019-04-07
NCT02817464Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory CycleCOMPLETEDPHASE12016-10-262018-12-032018-12-03
NCT02769091A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 DiabetesWITHDRAWNPHASE22016-09-302018-02-282018-01-31
NCT03200912An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic KeratosisCOMPLETEDPHASE32016-08-192017-03-222017-03-07
NCT03287791A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With RosaceaCOMPLETEDPHASE32016-07-192017-06-222017-06-22
NCT02840461Clinical Endpoint Study of Ivermectin 1% CreamCOMPLETEDPHASE32016-062016-122016-11
NCT03294538Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic VaginitisCOMPLETEDPHASE32016-05-182017-02-152017-02-15
NCT02680561A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With AsthmaCOMPLETEDPHASE12016-042016-082016-06
NCT02673567To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125COMPLETEDPHASE12016-03-312017-02-102016-12-16
NCT02629861Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineCOMPLETEDPHASE32016-03-232017-04-102017-04-10
NCT02621931Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineCOMPLETEDPHASE32016-03-222017-04-112017-04-11
NCT02344511Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous OsteomyelitisWITHDRAWNPHASE32016-032019-042018-10
NCT02638103Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of MigraineCOMPLETEDPHASE32016-02-262018-12-082018-06-06
NCT02498418Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's DiarrheaCOMPLETEDPHASE32016-01-062017-02-282017-02-28
NCT02651220Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne VulgarisCOMPLETEDPHASE32015-112016-102016-04
NCT02611804A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald ScalpCOMPLETEDPHASE32015-102016-082016-08
NCT02513160Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent AsthmaCOMPLETEDPHASE32015-09-302016-03-312016-03-31
NCT02501629An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsCOMPLETEDPHASE32015-09-292017-12-042017-06-19
NCT02452190Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsCOMPLETEDPHASE32015-09-282018-01-312017-12-04
NCT02496715Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in AsthmaticsWITHDRAWNPHASE32015-092016-122016-10
NCT02495857A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the KneeCOMPLETEDNA2015-08-152016-12-052016-12-05
NCT02487108Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following BunionectomyCOMPLETEDPHASE32015-08-112016-03-302016-03-30
NCT02499900Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®COMPLETEDPHASE42015-08-102017-06-022017-01-10
NCT02190721A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow InvolvementCOMPLETEDPHASE22015-05-122017-04-042017-04-04
NCT02437604Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and OlderCOMPLETEDPHASE12015-052015-092015-07
NCT02616614Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne VulgarisCOMPLETEDPHASE32015-052015-112015-10
NCT02410343Study of TV-1106 in Growth Hormone-Deficient AdultsTERMINATEDPHASE32015-04-302015-12-312015-12-31
NCT02410356Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)TERMINATEDPHASE32015-04-302016-04-302016-02-29
NCT02315144An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD PatientsTERMINATEDPHASE12015-042015-082015-08
NCT02512042Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both EyesCOMPLETEDPHASE32015-042016-052016-04
NCT02315131Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017TERMINATEDPHASE12015-032015-082015-08
NCT02616601Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic KeratosisCOMPLETEDPHASE32015-02-272015-09-172015-09-17
NCT02365636A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)COMPLETEDPHASE22015-02-262017-05-092017-05-09
NCT02791308Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic DermatitisCOMPLETEDPHASE32015-022016-072016-07
NCT02654769A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic KeratosisCOMPLETEDPHASE32015-022015-092015-09
NCT02284568A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to PlaceboCOMPLETEDPHASE22015-01-122017-10-012017-05-04
NCT02291861Addressing Involuntary Movements in Tardive DyskinesiaCOMPLETEDPHASE32014-10-312016-08-192016-08-19
NCT02215616A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of LaquinimodCOMPLETEDPHASE22014-10-282018-06-192018-06-19
NCT02198794Reducing Involuntary Movements in Participants With Tardive DyskinesiaCOMPLETEDPHASE32014-10-202020-12-142019-12-06
NCT02078960A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)TERMINATEDPHASE1, PHASE22014-10-092017-11-272017-07-06
NCT02306915PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian ParticipantsCOMPLETEDPHASE12014-102015-052015-03
NCT01940601Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid TumorsWITHDRAWNPHASE22014-092015-122015-11
NCT02203474A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary DiseaseWITHDRAWNPHASE22014-082014-082014-08
NCT02215941Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy VolunteersCOMPLETEDPHASE12014-082015-022014-11
NCT02202005Multiple Dose BE Study With Nevirapine 400mg PR TabletsCOMPLETEDPHASE12014-082015-082015-07
NCT02249663Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™UNKNOWNPHASE32014-082015-02
NCT02175771Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent AsthmaCOMPLETEDPHASE32014-072015-072015-07
NCT02184767Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic MedicationCOMPLETEDPHASE12014-072015-052015-03
NCT02674321A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)COMPLETEDPHASE12014-072015-062015-06
NCT02289352Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With RosaceaCOMPLETEDPHASE32014-072014-122014-12
NCT02195700Aim to Reduce Movements in Tardive DyskinesiaCOMPLETEDPHASE2, PHASE32014-062015-052015-05
NCT02141854Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaCOMPLETEDPHASE32014-062015-092015-09
NCT02139644Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaCOMPLETEDPHASE32014-062015-092015-09
NCT02267746A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne VulgarisCOMPLETEDPHASE32014-062014-092014-09
NCT02062463Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With AsthmaCOMPLETEDPHASE32014-05-282015-03-132015-03-13
NCT02126839A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric AsthmaticsCOMPLETEDPHASE32014-052015-022015-02
NCT02324270Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle SprainCOMPLETEDPHASE32014-052014-122014-12
NCT02092077A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient ChildrenTERMINATEDPHASE22014-04-302016-08-312016-04-30
NCT02068599A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single KneeCOMPLETEDPHASE22014-04-142015-05-042015-04-06
NCT02044276A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced NeutropeniaCOMPLETEDPHASE32014-03-312018-04-242017-08-29
NCT02246920Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis PatientsTERMINATEDPHASE32014-03-012014-07-142014-07-14
NCT02085863A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given TogetherCOMPLETEDPHASE12014-022014-112014-09
NCT02092571A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal WomenCOMPLETEDPHASE12014-022014-082014-07
NCT02025556A Multicenter Assessment of LBR-101 in High Frequency Episodic MigraineCOMPLETEDPHASE22014-01-312015-03-312015-01-31
NCT02021773Assessment of LBR-101 In Chronic MigraineCOMPLETEDPHASE22014-01-312015-03-312015-02-28
NCT01975298A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)WITHDRAWNPHASE32014-012014-032014-03
NCT02210689A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant WomenCOMPLETEDPHASE32014-012014-122014-10
NCT02040779A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent AsthmaCOMPLETEDPHASE32013-12-262014-12-242014-12-24
NCT02030457A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy AdultsCOMPLETEDPHASE12013-122014-062014-04
NCT02031640A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent AsthmaCOMPLETEDPHASE32013-122014-122014-11
NCT02040766A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent AsthmaCOMPLETEDPHASE32013-122016-032016-02
NCT01897896Alternatives for Reducing Chorea in Huntington DiseaseCOMPLETEDPHASE32013-11-122017-08-212017-08-21
NCT02120898A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic KeratosesCOMPLETEDPHASE32013-10-102014-04-302014-04-30
NCT01991509Safety and Bioavailability of IV and SC LBR-101COMPLETEDPHASE12013-102015-012014-12
NCT01795859First Time Use of SD-809 in Huntington DiseaseCOMPLETEDPHASE32013-08-052014-12-052014-12-05
NCT02684409Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute MigraineCOMPLETEDPHASE12013-082014-112014-11
NCT01903824Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy SubjectsCOMPLETEDPHASE12013-082013-122013-10
NCT01803555Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®COMPLETEDPHASE32013-07-042014-03-202014-03-20
NCT01899144Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric PatientsCOMPLETEDPHASE22013-072013-102013-10
NCT01922752To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid TumorsCOMPLETEDPHASE12013-072015-122015-09
NCT01922739Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release TabletsCOMPLETEDPHASE32013-072014-082014-08
NCT02120924A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial RosaceaCOMPLETEDPHASE32013-072014-092014-09
NCT01844869An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine MepesuccinateCOMPLETEDPHASE12013-072015-012014-12
NCT01874145Safety and Tolerability of Glatiramer AcetateCOMPLETEDPHASE32013-062014-052014-04
NCT01887366Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent SubjectsCOMPLETEDPHASE22013-062014-102014-09
NCT01990443Absolute Bioavailability of Reslizumab in Healthy SubjectsCOMPLETEDPHASE12013-062014-032013-12
NCT01879748A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of RasagilineCOMPLETEDPHASE12013-062013-112013-09
NCT01857323Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)COMPLETEDPHASE32013-052013-092013-08
NCT01844401Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With AsthmaCOMPLETEDPHASE12013-042013-102013-08
NCT01811576Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone DeficiencyCOMPLETEDPHASE22013-03-312013-08-052013-08-05
NCT01962987A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic KeratosisCOMPLETEDPHASE32013-032013-092013-09
NCT01789970Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back PainCOMPLETEDPHASE32013-032014-022014-02
NCT01791972Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)COMPLETEDPHASE32013-032013-062013-05
NCT01707992The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)COMPLETEDPHASE32013-02-202017-07-042015-04-13
NCT01850823Clinical Equivalence Study of Mometasone Nasal SprayCOMPLETEDPHASE32013-022013-122013-12
NCT01772368Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma SubjectsCOMPLETEDPHASE22013-012013-062013-06
NCT01783548Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)COMPLETEDPHASE32013-012013-102013-10
NCT01785433To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE1, PHASE22013-012013-082013-07
NCT01769677A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release TabletCOMPLETEDPHASE12013-012013-022013-01
NCT01747629Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State PharmacokineticsCOMPLETEDPHASE32012-122013-112013-10
NCT01424813A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent AsthmaCOMPLETEDPHASE32012-122013-112013-10
NCT01758978A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release TabletCOMPLETEDPHASE12012-122013-012013-01
NCT01723228Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's DiseaseCOMPLETEDPHASE42012-112015-012015-01
NCT01760980Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy SubjectsWITHDRAWNPHASE12012-112014-122014-12
NCT01697956Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)COMPLETEDPHASE32012-102013-022013-02
NCT01698320Safety Study of Albuterol Spiromax® in Subjects With AsthmaCOMPLETEDPHASE32012-102013-122013-12
NCT01686152Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic KeratosisCOMPLETEDPHASE32012-092013-082013-08
NCT01596621A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab TreatmentCOMPLETEDPHASE32012-08-062017-04-242015-06-18
NCT01563601Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung CancerWITHDRAWNPHASE32012-082018-012016-05
NCT01624480Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCOMPLETEDPHASE12012-072015-122015-09
NCT01585649PK/PD of XM22 in Children With Ewing Family of Tumors or RhabdomyosarcomaCOMPLETEDPHASE12012-072015-042014-06
NCT01576718A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsCOMPLETEDPHASE22012-042013-102013-07
NCT01578785An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)TERMINATEDPHASE32012-032012-112012-10
NCT01404117A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and TolerabilityWITHDRAWNPHASE22012-032014-012013-12
NCT01596673A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid UsersCOMPLETEDPHASE12012-032012-052012-05
NCT01508936Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaCOMPLETEDPHASE32012-022013-082013-08
NCT01479621A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsCOMPLETEDPHASE22012-012013-072013-07
NCT01523236Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/ActuationCOMPLETEDPHASE1, PHASE22011-122012-012012-01
NCT01388491A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy WomenCOMPLETEDPHASE22011-10-312012-09-302012-09-30
NCT01433432Open Label Extension Study to Protocol C2/13/DR-6MP-02WITHDRAWNPHASE22011-102012-082012-06
NCT01348919Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE1, PHASE22011-08-032013-03-142013-03-14
NCT01501799A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne VulgarisCOMPLETEDNA2011-072011-122011-12
NCT01290887Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaTERMINATEDPHASE32011-062015-012015-01
NCT01311713Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid TumorsTERMINATEDPHASE1, PHASE22011-05-022013-10-162013-10-16
NCT01345357Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell LymphomaCOMPLETEDPHASE12011-052013-012012-12
NCT01287039A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaCOMPLETEDPHASE32011-042014-032013-12
NCT01319279A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic ImpairmentCOMPLETEDPHASE12011-042011-082011-08
NCT01285323A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic AsthmaCOMPLETEDPHASE32011-032014-042014-04
NCT01305408Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCOMPLETEDPHASE32011-032013-072013-07
NCT01307319Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal AllergiesCOMPLETEDPHASE32011-032011-082011-07
NCT01319266A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal ImpairmentCOMPLETEDPHASE12011-032011-102011-10
NCT01270464A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic AsthmaCOMPLETEDPHASE32011-022013-092013-09
NCT01502020A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic KeratosesCOMPLETEDNA2011-022011-112011-08
NCT01291004A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral ContraceptivesCOMPLETEDPHASE12011-01-312012-03-312012-03-31
NCT01240876Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk HerniationCOMPLETEDPHASE1, PHASE22011-012013-042013-03
NCT01240694A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus ErythematosusTERMINATEDPHASE32010-12-092012-06-142012-06-14
NCT01240863Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of TimeCOMPLETEDPHASE32010-112011-082011-08
NCT01252186A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy WomenCOMPLETEDPHASE22010-112011-122011-12
NCT01094613Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's DiseaseTERMINATEDPHASE1, PHASE22010-112012-122012-12
NCT01085084A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus ArthritisCOMPLETEDPHASE22010-10-042012-11-122012-11-12
NCT01223365Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of TimeCOMPLETEDPHASE32010-102012-092012-09
NCT01218009A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed DosingTERMINATEDPHASE32010-102010-122010-12
NCT01085097A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus NephritisCOMPLETEDPHASE22010-09-012012-10-242012-10-24
NCT01205737A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma SubjectsCOMPLETEDPHASE12010-092013-092013-07
NCT01178125A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of PregnancyCOMPLETEDPHASE32010-082013-012013-01
NCT01088984Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute LeukemiaCOMPLETEDPHASE1, PHASE22010-082011-082011-08
NCT01159873Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal WomenTERMINATEDPHASE12010-072010-102010-10
NCT01167426Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) PatientsCOMPLETEDPHASE32010-072010-122010-11
NCT01126190Neugranin in Breast Cancer Participants Receiving Doxorubicin/DocetaxelCOMPLETEDPHASE32010-06-302012-02-292012-02-29
NCT01135459A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE22010-06-242012-06-302012-01-31
NCT01067521A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to PlaceboCOMPLETEDPHASE32010-06-222017-05-122012-05-08
NCT01133626Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)COMPLETEDPHASE32010-062010-092010-09
NCT01047319A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple SclerosisTERMINATEDPHASE32010-05-272017-06-302017-06-30
NCT00737932Laquinimod Phase IIa Study in Active Crohn's DiseaseCOMPLETEDPHASE22010-052011-122011-11
NCT01108341Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)COMPLETEDPHASE22010-052011-102011-07
NCT01134705Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)COMPLETEDPHASE32010-052010-102010-10
NCT01257906Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and PlaceboCOMPLETEDNA2010-052010-102010-10
NCT01121536Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderTERMINATEDPHASE32010-04-302013-10-312013-10-31
NCT01072630Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCOMPLETEDPHASE32010-032012-112012-11
NCT01080807Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work DisorderCOMPLETEDPHASE42010-032010-102010-10
NCT01123070TL011 in Severe, Active Rheumatoid Arthritis PatientsCOMPLETEDPHASE12010-02-052012-04-232012-04-23
NCT01058863A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent AsthmaCOMPLETEDPHASE22010-022010-062010-06
NCT01073163Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)COMPLETEDPHASE32010-022012-062012-06
NCT01056159A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)COMPLETEDPHASE12010-012010-062010-06
NCT01072929A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCOMPLETEDPHASE32010-012012-032012-03
NCT01023880Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent TherapyTERMINATEDPHASE1, PHASE22010-012013-012012-11
NCT01046214Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting ConditionsTERMINATEDPHASE12010-01
NCT01024608Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)COMPLETEDPHASE32009-12-312010-02-282010-02-28
NCT01381796Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy AdultsCOMPLETEDPHASE12009-122010-092010-09
NCT01049984Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseCOMPLETEDPHASE42009-122012-102012-10
NCT00977665Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)COMPLETEDPHASE22009-122011-102011-10
NCT00988052A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease CourseTERMINATEDPHASE32009-11-102017-07-012017-07-01
NCT00988247Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic RhinitisCOMPLETEDPHASE32009-10-312011-02-282011-02-28
NCT00996580A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of PregnancyCOMPLETEDPHASE32009-102011-092011-09
NCT00964730A Phase 1 Study to Investigate the Effects of Talampanel on the Heart RhythmCOMPLETEDPHASE12009-102010-022010-01
NCT00982150Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)TERMINATEDPHASE22009-092010-062010-06
NCT00990340Comparison of a Needle-free Injection Method With a Needle-syringe Injection MethodCOMPLETEDPHASE42009-092010-082010-06
NCT00983437Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain InjuryTERMINATEDPHASE32009-08-312011-01-312011-01-31
NCT00991510Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant PatientsTERMINATEDPHASE42009-082010-102010-10
NCT00947752Safety of New Formulation of Glatiramer AcetateCOMPLETEDPHASE32009-072009-112009-09
NCT00924560A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent FemalesCOMPLETEDPHASE22009-062012-082012-08
NCT00891839Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell LymphomaCOMPLETEDPHASE22009-062014-052011-12
NCT00920855Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaCOMPLETEDPHASE1, PHASE22009-062011-122011-07
NCT00920595Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid TumorsCOMPLETEDPHASE12009-062011-102011-10
NCT00863850Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory MalignancyCOMPLETEDPHASE12009-052010-032010-02
NCT00868361A Study to Investigate the Absorption, Metabolism and Excretion of TalampanelTERMINATEDPHASE12009-052009-092009-09
NCT00893789Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain InjuryTERMINATEDPHASE32009-04-302011-01-312011-01-31
NCT00877006Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT StudyCOMPLETEDPHASE32009-04-302012-03-312012-03-31
NCT00854360Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SARCOMPLETEDPHASE22009-032009-052009-05
NCT01537692Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal AerosolCOMPLETEDPHASE12009-032009-062009-04
NCT01095640Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical GelCOMPLETEDNA2009-032009-122009-12
NCT02592031Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young WomenCOMPLETEDPHASE12009-022009-122009-05
NCT00856635A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)COMPLETEDPHASE32009-022011-022010-12
NCT00806546An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve MonthsCOMPLETEDPHASE32009-022011-052011-05
NCT00781456A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine HeadachesCOMPLETEDPHASE22009-012011-082011-08
NCT00792103An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsCOMPLETEDPHASE32009-012010-092010-09
NCT00724815The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute MigraineCOMPLETEDPHASE32009-012009-072009-07
NCT00842829Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant PatientsTERMINATEDPHASE42009-012011-052011-05
NCT00825227Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other AgentsTERMINATEDPHASE22008-122010-022009-10
NCT00813488Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic PainCOMPLETEDPHASE32008-122010-012009-11
NCT00774982Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease PatientsCOMPLETEDPHASE12008-122009-022009-02
NCT00723983Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine PeriodCOMPLETEDPHASE12008-112009-092009-09
NCT00724048A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's DiseaseCOMPLETEDPHASE22008-10-242010-07-262010-07-26
NCT00712881Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast CancerCOMPLETEDPHASE22008-10-132015-09-172015-09-17
NCT00777556Emergency Contraception Actual Use StudyCOMPLETEDPHASE32008-102010-122010-12
NCT00782769A Safety Extension Study of DR-OXY-301COMPLETEDPHASE32008-092010-072010-07
NCT00711516Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory PerformanceCOMPLETEDPHASE42008-092009-102009-09
NCT00758498Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag DisorderCOMPLETEDPHASE32008-092009-022009-02
NCT00772005Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaCOMPLETEDPHASE22008-092010-052010-03
NCT00696332Talampanel for Amyotrophic Lateral Sclerosis (ALS)COMPLETEDPHASE22008-092010-052010-04
NCT00837265Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/DocetaxelCOMPLETEDPHASE2, PHASE32008-08-212009-06-262009-06-26
NCT01344369Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted ConditionsCOMPLETEDPHASE12008-082008-092008-09
NCT00635089Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic EsophagitisCOMPLETEDPHASE32008-072012-012012-01
NCT00724841A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic MelanomaTERMINATEDPHASE1, PHASE22008-062010-082008-07
NCT00720018Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy VolunteersCOMPLETEDPHASE12008-062008-072008-07
NCT00948428Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic KeratosisCOMPLETEDPHASE32008-052009-042009-03
NCT00685113A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive BladderCOMPLETEDPHASE32008-052010-032010-03
NCT00682981A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)COMPLETEDPHASE1, PHASE22008-052011-112011-11
NCT00665223A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's DiseaseCOMPLETEDPHASE32008-04-242010-06-142010-06-14
NCT00605215BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)COMPLETEDPHASE32008-04-242011-06-102011-06-10
NCT00587288Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled AsthmaCOMPLETEDPHASE22008-042010-032010-03
NCT00675350Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic TumorsCOMPLETEDPHASE12008-042009-012008-09
NCT00684918Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)COMPLETEDPHASE22008-042009-122009-08
NCT00538434Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 YearsCOMPLETEDPHASE2, PHASE32008-032009-102009-10
NCT00615251A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro FertilizationCOMPLETEDPHASE32008-022009-082009-08
NCT00464958One Year Extension Study To Protocol C2/5/TZ:MS-05TERMINATEDPHASE1, PHASE22008-012008-122008-12
NCT00586651Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential ThrombocytosisCOMPLETEDPHASE22007-122010-092009-10
NCT00592839Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal WomenCOMPLETEDPHASE42007-122009-022009-02
NCT00509145Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)COMPLETEDPHASE32007-11-132010-11-082010-11-08
NCT00546650Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®COMPLETEDPHASE12007-112008-032007-12
NCT00544882A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021COMPLETEDPHASE32007-10-312008-03-312008-03-31
NCT00518986Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionCOMPLETEDPHASE42007-102009-032009-03
NCT00513305Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid LeukemiaTERMINATEDPHASE32007-102009-122009-07
NCT00875264Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced CancerCOMPLETEDPHASE12007-092011-062011-06
NCT00577655Albuterol HFA MDI in Pediatric Participants With AsthmaCOMPLETEDPHASE32007-082008-072008-07
NCT01157169Buprenorphine 8 mg Sublingual Tablets Under Fasting ConditionsCOMPLETEDPHASE12007-082007-092007-09
NCT00530062Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With AsthmaCOMPLETEDPHASE42007-07-252008-10-242008-10-24
NCT00487942Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive DeficitsCOMPLETEDPHASE22007-072007-122007-12
NCT00463047Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through PainCOMPLETEDPHASE32007-072009-022009-02
NCT01182636Bioequivalence of Adapalene Topical Gel in Patients With Acne VulgarisCOMPLETEDPHASE12007-072008-042008-04
NCT00481195Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCOMPLETEDPHASE22007-062008-122008-12
NCT01439230Donepezil 10 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12007-062007-082007-08
NCT01439243Donepezil 10 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12007-062007-072007-07
NCT00864604Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy VolunteersCOMPLETEDPHASE12007-042007-052007-05
NCT00455260A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-DeficiencyCOMPLETEDPHASE12007-042007-10
NCT00462943Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CMLCOMPLETEDPHASE22007-03-072013-06-272009-08-04
NCT00427856Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)COMPLETEDPHASE22007-032009-072009-02
NCT00457574Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or LymphomasWITHDRAWNPHASE12007-032010-082009-07
NCT01157182Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting ConditionsCOMPLETEDPHASE12007-022007-042007-04
NCT00864968Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy VolunteersCOMPLETEDPHASE12007-022007-032007-03
NCT00859430Levetiracetam 1000 mg Under Non-Fasting ConditionsCOMPLETEDPHASE12007-012007-012007-01
NCT00859521Levetiracetam 1000 mg Under Fasting ConditionsCOMPLETEDPHASE12007-012007-012007-01
NCT01181726Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed ConditionsCOMPLETEDPHASE12007-012007-022007-02
NCT00909610Ursodiol Tablets 500 mg Under Fasting ConditionsCOMPLETEDPHASE12006-122007-012007-01
NCT00413114Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)COMPLETEDPHASE22006-122009-112009-02
NCT00387010Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough PainTERMINATEDPHASE32006-122007-102007-10
NCT01340625Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting ConditionsCOMPLETEDPHASE12006-122007-012007-01
NCT00036296Effects of Talampanel on Patients With Advanced Parkinson's DiseaseCOMPLETEDPHASE1, PHASE22006-122007-022007-02
NCT00287157Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)COMPLETEDPHASE12006-122007-05
NCT00358293Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant SpasticityCOMPLETEDPHASE1, PHASE22006-122007-02
NCT00829790Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed ConditionsCOMPLETEDPHASE12006-102006-102006-10
NCT00911274Mycophenolate Mofetil 250 mg Capsules Under Fasting ConditionsCOMPLETEDPHASE12006-102006-112006-11
NCT00829764Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting ConditionsCOMPLETEDPHASE12006-102006-102006-10
NCT00910663Mycophenolate Mofetil 250 mg Capsules Under Fed ConditionsCOMPLETEDPHASE12006-102006-112006-11
NCT00405951Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22006-102009-092008-11
NCT00407303Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)COMPLETEDPHASE1, PHASE22006-102009-112009-03
NCT00236093Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough PainCOMPLETEDPHASE22006-102006-12
NCT00394771A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to SeasonaleCOMPLETEDPHASE22006-102008-032008-03
NCT00399477A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCOMPLETEDPHASE42006-102007-072007-07
NCT00864357A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12006-102006-102006-10
NCT00864526A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12006-102006-102006-10
NCT00974012Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12006-102006-102006-10
NCT00375219Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene MutationCOMPLETEDPHASE22006-09-202013-06-282010-03-23
NCT00909753Ursodiol 500 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12006-092006-102006-10
NCT00382408A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001COMPLETEDPHASE32006-092007-122007-12
NCT00908128Mycophenolate Mofetil Tablets Under Fed ConditionsCOMPLETEDPHASE12006-082006-082006-08
NCT00361569A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal AtrophyCOMPLETEDPHASE32006-082007-092007-09
NCT00343733Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic PainCOMPLETEDPHASE32006-082007-07
NCT00362479Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral ContraceptiveCOMPLETEDPHASE32006-082007-072007-07
NCT00337779Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).COMPLETEDPHASE32006-082008-102008-10
NCT00759902Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted ConditionsCOMPLETEDPHASE12006-082006-102006-09
NCT00864279A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12006-082006-092006-09
NCT00863902A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12006-082006-092006-09
NCT00759915Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed ConditionsCOMPLETEDPHASE12006-082006-102006-09
NCT00974441Divalproex Sodium 500 mg Extended Release Tablets Under Fasting ConditionsCOMPLETEDPHASE12006-082006-092006-09
NCT00326625Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)COMPLETEDPHASE22006-07-272008-06-172008-06-17
NCT00907907Mycophenolate Mofetil Tablets Under Fasting ConditionsCOMPLETEDPHASE12006-072006-082006-08
NCT00360035Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid MetaplasiaCOMPLETEDPHASE22006-072009-022008-03
NCT00359892Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's LymphomaCOMPLETEDPHASE22006-072008-112007-09
NCT01182207Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12006-072006-082006-08
NCT01188057A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12006-072006-082006-08
NCT00287170Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's DiseaseCOMPLETEDPHASE1, PHASE22006-072007-12
NCT00308685Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric AsthmaticsCOMPLETEDPHASE32006-06-102006-12-042006-12-04
NCT00343811Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil TreatmentCOMPLETEDPHASE32006-062006-09
NCT01182194Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.COMPLETEDPHASE12006-062006-082006-08
NCT01188031A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting ConditionsCOMPLETEDPHASE12006-062006-072006-07
NCT00768183Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to WaterCOMPLETEDPHASE12006-052006-072006-07
NCT00315276Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHDCOMPLETEDPHASE22006-052007-01
NCT0126094810 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12006-042006-052006-05
NCT0126092210 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.COMPLETEDPHASE12006-042006-052006-05
NCT00871364A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed ConditionsCOMPLETEDPHASE12006-042006-052006-05
NCT00242827Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple MyelomaTERMINATEDPHASE22006-042007-05
NCT00865111A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12006-032006-042006-04
NCT00830206A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting ConditionsCOMPLETEDPHASE12006-012006-012006-01
NCT00240006A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® AloneCOMPLETEDPHASE42006-012007-092007-01
NCT00863863A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting ConditionsCOMPLETEDPHASE12006-012006-012006-01
NCT00745615An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the DiseaseTERMINATEDPHASE22005-12-072017-07-232017-07-23
NCT00267592Safety and Efficacy of Talampanel in Glioblastoma MultiformeCOMPLETEDPHASE22005-122011-022008-09
NCT00272935A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot FlashesCOMPLETEDPHASE32005-122007-052007-05
NCT00864500Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult SubjectsCOMPLETEDPHASE12005-112006-022006-02
NCT00256204A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's DiseaseCOMPLETEDPHASE32005-112009-062008-04
NCT00864071A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting ConditionsCOMPLETEDPHASE12005-112005-112005-11
NCT00849485Levetiracetam 750 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12005-112005-112005-11
NCT00830336A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting ConditionsCOMPLETEDPHASE12005-102005-112005-11
NCT00232999Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic AsthmaCOMPLETEDPHASE22005-102006-012005-12
NCT00864240The Dose-response "Pilot" Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult SubjectsCOMPLETEDPHASE12005-102005-102005-10
NCT00114959Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)TERMINATEDPHASE22005-102009-032008-06
NCT00438178Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological MalignanciesCOMPLETEDPHASE12005-102007-10
NCT00139841Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to RituximabCOMPLETEDPHASE32005-102009-102007-07
NCT00228566Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeCOMPLETEDPHASE32005-102006-07
NCT00864435A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-102005-112005-11
NCT00864149A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12005-102005-112005-11
NCT00849862Levetiracetam 750 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-102005-112005-11
NCT00250341Non-invasive Measures of Distal Lung Disease in AsthmaticsCOMPLETEDPHASE42005-09-302007-09-302007-09-30
NCT00834717Granisetron 1 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-092005-092005-09
NCT00214955Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough PainCOMPLETEDPHASE32005-092006-05
NCT00214942Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough PainCOMPLETEDPHASE32005-092006-03
NCT00228540Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHDCOMPLETEDPHASE32005-092006-09
NCT00196391A Trial to Evaluate DR-2021 in Women With Secondary AmenorrheaCOMPLETEDPHASE22005-092007-042007-04
NCT01183390Anastrozole 1 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12005-092005-102005-10
NCT00865657A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12005-092005-092005-09
NCT00865761A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-092005-092005-09
NCT00239993A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®COMPLETEDPHASE42005-082006-022005-12
NCT00236080Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGILCOMPLETEDPHASE32005-082005-12
NCT01182181Anastrozole 1 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-082005-092005-09
NCT00834522Granisetron 1 mg Tablets, Non-fastingCOMPLETEDPHASE12005-072005-072005-07
NCT00834535Cefdinir Capsules 300 mg, Non-fastingCOMPLETEDPHASE12005-072005-082005-08
NCT00835484Cefdinir Capsules 300 mg, FastingCOMPLETEDPHASE12005-072005-072005-07
NCT00849797Oxcarbazepine 600 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12005-072005-072005-07
NCT00117260Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral DensityWITHDRAWNPHASE32005-072007-082007-07
NCT00203151A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of LupusTERMINATEDPHASE22005-072007-022007-02
NCT00865891A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-072005-072005-07
NCT00112411Comparison of Two Bronchodilator Inhalers in Pediatric AsthmaticsCOMPLETEDPHASE22005-06-302005-09-302005-09-30
NCT00829426Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting ConditionsCOMPLETEDPHASE12005-062005-062005-06
NCT00830024Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting ConditionsCOMPLETEDPHASE12005-062005-062005-06
NCT00196326Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral ContraceptiveCOMPLETEDPHASE32005-062007-062007-06
NCT00196339A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer PatientsCOMPLETEDPHASE22005-062008-012008-01
NCT00117468Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase ReplacementCOMPLETEDPHASE22005-062006-042006-04
NCT00117481Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic PainCOMPLETEDPHASE22005-062007-122007-12
NCT00117273A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive RegimensCOMPLETEDPHASE32005-062006-06
NCT00236119Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe PsoriasisCOMPLETEDPHASE22005-062007-102007-10
NCT00196313A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic PainCOMPLETEDPHASE22005-052008-102008-10
NCT00864747A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12005-052005-052005-05
NCT00864617A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12005-052005-052005-05
NCT00830258Pravastatin Sodium 80 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-042005-042005-04
NCT00850174Oxcarbazepine 600 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-042005-052005-05
NCT00870142A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-042005-052005-05
NCT00870571A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed ConditionsCOMPLETEDPHASE12005-042005-052005-05
NCT00865215A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-042005-042005-04
NCT00829309Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting ConditionsCOMPLETEDPHASE12005-032005-032005-03
NCT00835549Cefdinir for Oral Suspension 250 mg/5mL, Non-fastingCOMPLETEDPHASE12005-032005-032005-03
NCT00228605Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough PainCOMPLETEDPHASE32005-032007-05
NCT00349193A Study to Evaluate the Effectiveness, Tolerability and Safety of LaquinimodCOMPLETEDPHASE22005-032006-082006-06
NCT00834574Cefdinir for Oral Suspension 250 mg/5mL, FastingCOMPLETEDPHASE12005-022005-032005-03
NCT01074450Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12005-022005-032005-03
NCT01074463Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12005-022005-032005-03
NCT00105287Treatment of Breakthrough Pain in Opioid Tolerant Cancer PatientsCOMPLETEDPHASE32005-012007-092006-09
NCT00214994Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.COMPLETEDPHASE32005-012006-12
NCT00196365A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic PainCOMPLETEDPHASE32005-012007-072007-07
NCT00203047Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer AcetateTERMINATEDPHASE42005-012009-052009-05
NCT00214968Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive SleepinessCOMPLETEDPHASE32005-012005-102005-10
NCT01149499Valacyclovir 1000 mg Tablet Under Fasting ConditionsCOMPLETEDPHASE12005-012005-012005-01
NCT00203099Safety and Efficacy Study of Copaxone Administered in Combination With N-AcetylcysteineCOMPLETEDPHASE22004-122008-062006-08
NCT00104091Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain TumorsCOMPLETEDPHASE22004-122007-062007-04
NCT01190761Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed ConditionsCOMPLETEDPHASE12004-122004-122004-12
NCT01149746Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting ConditionsCOMPLETEDPHASE12004-122004-122004-12
NCT01149733Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed ConditionsCOMPLETEDPHASE12004-112004-112004-11
NCT01190748Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12004-112004-122004-12
NCT00236015A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCOMPLETEDPHASE32004-112006-03
NCT00870480A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-112004-112004-11
NCT00871247A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12004-112004-112004-11
NCT00196378A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal AtrophyCOMPLETEDPHASE32004-112006-022006-02
NCT00830219The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12004-112004-112004-11
NCT00094016Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic ChildrenCOMPLETEDPHASE32004-10-312006-06-302006-06-30
NCT00840073Trandolapril 4 mg Tablet Under Non-Fasting ConditionsCOMPLETEDPHASE12004-102004-112004-11
NCT00840632Trandolapril 4 mg Tablet Under Fasting ConditionsCOMPLETEDPHASE12004-102004-112004-11
NCT00236067A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCOMPLETEDPHASE32004-102006-03
NCT00236054A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCOMPLETEDPHASE32004-102005-12
NCT00107848PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeCOMPLETEDPHASE32004-102005-09
NCT00107809Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea SyndromeCOMPLETEDPHASE32004-102005-09
NCT00196404Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive BladderCOMPLETEDPHASE22004-102006-122006-12
NCT00240032A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.COMPLETEDPHASE42004-102006-072006-06
NCT00864448A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting ConditionsCOMPLETEDPHASE12004-102004-102004-10
NCT00863915A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on ApplesauceCOMPLETEDPHASE12004-102004-102004-10
NCT00829504Ropinirole 0.25 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-102004-102004-10
NCT00107796Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCOMPLETEDPHASE32004-102005-09
NCT01149460Valacyclovir 1000 mg Tablet Under Fed ConditionsCOMPLETEDPHASE12004-092004-092004-09
NCT00834275Cefadroxil 500 mg Capsules Under Fasting ConditionsCOMPLETEDPHASE12004-092004-102004-10
NCT00835081Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.COMPLETEDPHASE12004-092004-102004-10
NCT00600964A Phase I/II Study of GX15-070MS in Untreated CLLCOMPLETEDPHASE12004-092006-012006-01
NCT00151736Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)TERMINATEDPHASE22004-092008-022006-02
NCT00865371A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12004-092004-092004-09
NCT00759954Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on ApplesauceCOMPLETEDPHASE12004-092004-102004-10
NCT00864162A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed ConditionsCOMPLETEDPHASE12004-092004-102004-10
NCT00759759Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting ConditionsCOMPLETEDPHASE12004-092004-102004-09
NCT00834444Famciclovir 500 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12004-082004-092004-09
NCT00829530Ramipril 10 mg Capsule in Healthy Subjects Under Fed ConditionsCOMPLETEDPHASE12004-082004-102004-10
NCT00834431Famciclovir 500 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-082004-092004-09
NCT00828321Ramipril 10 mg Capsule in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12004-082004-102004-10
NCT00829452Ramipril 10 mg Capsule in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12004-082004-102004-10
NCT00220922A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.COMPLETEDPHASE42004-082006-022005-10
NCT00759356Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed ConditionsCOMPLETEDPHASE12004-082004-092004-09
NCT00865410A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-082004-092004-09
NCT00864019A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12004-082004-082004-08
NCT00864344A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-082004-082004-08
NCT00846885Sumatriptan Succinate 100 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12004-082004-102004-09
NCT00104273Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)COMPLETEDPHASE22004-082007-03
NCT00109668Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled CorticosteroidsCOMPLETEDPHASE32004-07-312006-09-302006-09-30
NCT00202995Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMSTERMINATEDPHASE42004-072007-102007-10
NCT00865462A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12004-072004-072004-07
NCT00085774Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced AsthmaCOMPLETEDPHASE32004-06-302004-09-302004-09-30
NCT00829673Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12004-062004-062004-06
NCT00829712Dexmethylphenidate Hydrochloride Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-062004-062004-06
NCT00203112Safety and Efficacy Study of Copaxone Administered in Combination With MinocyclineCOMPLETEDPHASE22004-062006-072006-06
NCT00203138Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCOMPLETEDPHASE32004-062006-122006-11
NCT00863941A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-062004-072004-07
NCT008345875 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-FastingCOMPLETEDPHASE12004-062004-062004-06
NCT008354975 mg Glipizide/500 mg Metformin Hydrochloride Tablets, FastingCOMPLETEDPHASE12004-062004-062004-06
NCT00236145Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough PainCOMPLETEDPHASE32004-062005-08
NCT00835354Cefprozil for Oral Suspension 250 mg/5 mL, Non-fastingCOMPLETEDPHASE12004-052004-052004-05
NCT00782548Comparative Study to Evaluate KADIAN and Avinza in Healthy AdultsCOMPLETEDPHASE42004-052004-062004-06
NCT00228553Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive SleepinessCOMPLETEDPHASE32004-052006-07
NCT01045967Lansoprazole 30 mg DR Capsule Fasting StudyCOMPLETEDPHASE12004-052004-072004-06
NCT00834977Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12004-042004-052004-05
NCT00835614Cefprozil for Oral Suspension 250 mg/5 mL, FastingCOMPLETEDPHASE12004-042004-042004-04
NCT00076349SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)COMPLETEDPHASE22004-042008-032005-12
NCT00236041Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)COMPLETEDPHASE22004-042006-08
NCT00865436A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-042004-042004-04
NCT00105937OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer PatientsCOMPLETEDPHASE32004-042006-11
NCT00835367Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed ConditionsCOMPLETEDPHASE12004-032004-032004-03
NCT01149473Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting ConditionsCOMPLETEDPHASE12004-032004-042004-04
NCT00080288Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSDCOMPLETEDPHASE32004-032004-12
NCT00079677Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) SyndromeCOMPLETEDPHASE32004-032004-10
NCT00078377Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With NarcolepsyCOMPLETEDPHASE32004-032005-012005-01
NCT00081601Study of CEP-701 in Treatment of Prostate CancerCOMPLETEDPHASE22004-032005-062005-05
NCT00839930Cilostazol 50 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-022004-022004-02
NCT00840879Meloxicam 15 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12004-022004-022004-02
NCT00840476Meloxicam 15 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-022004-022004-02
NCT00829868Zaleplon 10 mg Capsules Under Non-Fasting ConditionsCOMPLETEDPHASE12004-022004-032004-03
NCT00829998Zaleplon 10mg Capsules Under Fasting ConditionsCOMPLETEDPHASE12004-022004-022004-02
NCT00078325Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)COMPLETEDPHASE32004-022004-112004-11
NCT00071552Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult PatientsTERMINATEDPHASE42004-01-312006-07-312006-07-31
NCT00078312Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep DisorderCOMPLETEDPHASE32004-012006-072006-07
NCT00666224Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated SyndromeCOMPLETEDPHASE32004-012010-062007-10
NCT01046253Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle StudyCOMPLETEDPHASE12004-012004-012004-01
NCT01149486Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12004-012004-022004-02
NCT00865748A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-012004-012004-01
NCT00835588Pantoprazole Sodium 40 mg DR Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-122003-122003-12
NCT00865605Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult SubjectsCOMPLETEDPHASE12003-122004-072004-07
NCT00865267The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult SubjectsCOMPLETEDPHASE12003-122003-122003-12
NCT00835393Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12003-122003-122003-12
NCT00838630Cilostazol 100 mg Tablet Formulations Under Fasting ConditionsCOMPLETEDPHASE12003-112003-112003-11
NCT00836056Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12003-112003-112003-11
NCT00836004Clindamycin 300 mg Capsules in Healthy Subjects Under Fed ConditionsCOMPLETEDPHASE12003-112003-112003-11
NCT00835042Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-102003-112003-11
NCT00834067Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12003-102003-112003-11
NCT01124175Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting ConditionsCOMPLETEDPHASE12003-102003-112003-11
NCT00079482Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)COMPLETEDPHASE22003-102010-012009-03
NCT00071539Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain TumorsCOMPLETEDPHASE22003-102006-072006-01
NCT01124162Losartan 100 mg Tablets in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12003-102003-112003-11
NCT00840281Cefprozil 500 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00835536Ribavirin 200 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12003-092003-102003-10
NCT00835705Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00836901Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00840866Cefprozil 500 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00835146Ribavirin 200 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-092003-102003-10
NCT00069758Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's LymphomaCOMPLETEDPHASE22003-092007-042007-04
NCT00214981Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHDCOMPLETEDPHASE32003-092006-092006-09
NCT00972855Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00973050Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00834990Divalproex Sodium Delayed-Release Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00834639Divalproex Sodium Delayed-Release Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-092003-092003-09
NCT00834743Metformin ER 750 mg Tablets, FastingCOMPLETEDPHASE12003-082003-082003-08
NCT00834613Metformin ER 750 mg Tablets, FedCOMPLETEDPHASE12003-082003-082003-08
NCT00233675Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety DisorderCOMPLETEDPHASE32003-082005-02
NCT01046084Lansoprazole 30 mg DR Capsule Replicate Food StudyCOMPLETEDPHASE12003-082003-092003-09
NCT00865852A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12003-082003-082003-08
NCT00865072A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-082003-082003-08
NCT00202982A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved DoseCOMPLETEDPHASE22003-082005-092005-09
NCT0083557515 mg Mirtazapine Orally Disintegrating Tablets, FastingCOMPLETEDPHASE12003-072003-082003-08
NCT0083419715 mg Mirtazapine Orally Disintegrating Tablets, Non-FastingCOMPLETEDPHASE12003-072003-082003-08
NCT00062504Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasTERMINATEDPHASE22003-072006-042006-01
NCT00865943A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-072003-082003-08
NCT00835211Desmopressin Acetate 0.2 mg Tablets, FastingCOMPLETEDPHASE12003-072003-082003-08
NCT00203073A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.COMPLETEDPHASE22003-062005-042005-01
NCT00864565A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal SystemCOMPLETEDPHASE12003-062003-062003-06
NCT00865085A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-062003-072003-07
NCT00864890A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12003-062003-072003-07
NCT00840203Mesalamine 4 gm/60 mL Rectal EnemaCOMPLETEDPHASE12003-052003-062003-06
NCT00196352A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.COMPLETEDPHASE32003-052006-112006-11
NCT00836472Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FastingCOMPLETEDPHASE12003-042003-042003-04
NCT00841542Amlodipine 10 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-042003-052003-05
NCT00841815Amlodipine 10 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12003-042003-052003-05
NCT00054964Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler TechniqueCOMPLETEDPHASE22003-03-312003-08-312003-08-31
NCT00835172Glimepiride 4 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12003-032003-032003-03
NCT00847405Sumatriptan Succinate 100 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-032003-032003-03
NCT00834340Glimepiride 4 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12003-022003-032003-03
NCT00835991Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FedCOMPLETEDPHASE12003-022003-022003-02
NCT00934921Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12003-022003-022003-02
NCT01282814Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle StudyCOMPLETEDPHASE12003-022003-032003-03
NCT00934180Ondansetron HCl Orally Disintegrating Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-122002-122002-12
NCT00834964Venlafaxine 25 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-122002-122002-12
NCT00834249Venlafaxine 25 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12002-122002-122002-12
NCT00864734A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12002-112002-112002-11
NCT00865241A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-112002-112002-11
NCT00841698Paroxetine Hydrochloride 40 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-102002-102002-10
NCT00840411Clarithromycin 500 mg Extended Release Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-092002-102002-10
NCT00835692Clarithromycin 500 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-092002-092002-09
NCT00834756Azithromycin 600 Mg Tablets, FastingCOMPLETEDPHASE12002-092002-102002-10
NCT01282801Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed ConditionsCOMPLETEDPHASE12002-092002-102002-10
NCT01260896Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting ConditionsCOMPLETEDPHASE12002-092002-102002-10
NCT00841659Paroxetine Hydrochloride 40 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12002-082002-082002-08
NCT00840099600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting ConditionsCOMPLETEDPHASE12002-082002-082002-08
NCT00840216Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.COMPLETEDPHASE12002-082002-082002-08
NCT00840840600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed ConditionsCOMPLETEDPHASE12002-082002-082002-08
NCT00836706Clarithromycin 500 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12002-072002-072002-07
NCT00834132Azithromycin 600 Mg Tablets, FedCOMPLETEDPHASE12002-072002-082002-08
NCT00835666Finasteride 5 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-062002-062002-06
NCT00834418Leflunomide 20 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-062002-072002-07
NCT00835796Finasteride 5 mg Tablets, Non-fastingCOMPLETEDPHASE12002-062002-072002-07
NCT00905164Topiramate 25 mg Capsules Under Fasting ConditionsCOMPLETEDPHASE12002-062002-062002-06
NCT00905346Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting ConditionsCOMPLETEDPHASE12002-062002-072002-07
NCT00904943Topiramate 25 mg Capsules Under Fed ConditionsCOMPLETEDPHASE12002-062002-072002-07
NCT00203164Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCOMPLETEDPHASE32002-052006-092005-07
NCT00834405Leflunomide 20 mg Tablets, Non-FastingCOMPLETEDPHASE12002-042002-052002-05
NCT00830414Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal WomenCOMPLETEDPHASE12002-042002-092002-09
NCT00836667Sertraline Hydrochloride 100 mg Tablets, FedCOMPLETEDPHASE12002-032002-042002-04
NCT00833937Zolpidem Tartrate 10 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12002-032002-032002-03
NCT00836849Sertraline Hydrochloride 100 mg Tablets, FastingCOMPLETEDPHASE12002-032002-042002-04
NCT00040404Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseTERMINATEDPHASE2, PHASE32002-032005-082005-08
NCT00865839A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-032002-032002-03
NCT00864669A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12002-032002-032002-03
NCT00835276Fexofenadine Hydrochloride 180 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-032002-032002-03
NCT00838136Lamotrigine 25 mg Chewable Tablets, Non-FastingCOMPLETEDPHASE12002-022002-032002-03
NCT00833521Zolpidem Tartrate 10 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12002-022002-022002-02
NCT00838279Lamotrigine 25 mg Chewable Tablets, FastingCOMPLETEDPHASE12002-022002-032002-03
NCT00293111Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)TERMINATEDPHASE22002-022003-10
NCT00035503Multicenter Trial For Patients With Acute Crohn's DiseaseCOMPLETEDPHASE22002-01-312004-01-312004-01-31
NCT00834561Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting ConditionsCOMPLETEDPHASE12002-012002-022002-02
NCT01020396Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial VaginosisCOMPLETEDPHASE1, PHASE22002-012003-032003-03
NCT00835263Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting ConditionsCOMPLETEDPHASE12002-012002-022002-02
NCT00833586Terbinafine HCl 250 mg Tablet Under Fasting ConditionsCOMPLETEDPHASE12002-012002-012002-01
NCT00833664Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting ConditionsCOMPLETEDPHASE12002-012002-012002-01
NCT00030186Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 MutationCOMPLETEDPHASE22002-012003-022003-02
NCT00034814Multicenter Trial for Adults With Partial SeizuresCOMPLETEDPHASE22002-012006-012006-01
NCT00835640Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting ConditionsCOMPLETEDPHASE12002-012002-012002-01
NCT00834795Carvedilol 25 mg in 36 Fasted, Healthy, Adult SubjectsCOMPLETEDPHASE12001-122001-122001-12
NCT00840606Buspirone Hydrochloride 30mg Tablets, FastingCOMPLETEDPHASE12001-122002-042001-12
NCT00840398Buspirone Hydrochloride 30mg Tablets, Non-FastingCOMPLETEDPHASE12001-122001-122001-12
NCT00834873Carvedilol (25 mg) in 24 Fed, Healthy, Adult SubjectsCOMPLETEDPHASE12001-122001-122001-12
NCT01020877Bioavailability of Metronidazole Vaginal Gel in Healthy SubjectsCOMPLETEDPHASE12001-112002-012001-11
NCT00203177Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.COMPLETEDPHASE32001-102006-12
NCT00865384A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting ConditionsCOMPLETEDPHASE12001-092001-092001-09
NCT00865696A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12001-092001-092001-09
NCT00905606Topiramate 25 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12001-062001-062001-06
NCT00830349Risperidone 1 mg Tablet in Healthy Subjects Under Fasting ConditionsCOMPLETEDPHASE12001-062004-072001-07
NCT00829894Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed ConditionsCOMPLETEDPHASE12001-062001-072001-07
NCT00905567Topiramate 25 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12001-062001-062001-06
NCT0124728590 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting ConditionsCOMPLETEDPHASE12001-052001-072001-07
NCT0124727290 mg Fluoxetine Hydrochloride Capsules Under Fasting ConditionsCOMPLETEDPHASE12001-052001-072001-07
NCT00836537Benazepril HCl 40 mg Tablets, FedCOMPLETEDPHASE12001-032001-032001-03
NCT00836576Benazepril HCl 40 mg Tablets, FastingCOMPLETEDPHASE12001-022001-032001-03
NCT00865059A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting ConditionsCOMPLETEDPHASE12001-022001-032001-02
NCT00865423A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Fasting ConditionsCOMPLETEDPHASE12001-022001-032001-02
NCT00203125A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.COMPLETEDPHASE32000-102003-012003-01
NCT00834379Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12000-092000-092000-09
NCT00834847Pravastatin Sodium 40 mg Tablets Food Challenge StudyCOMPLETEDPHASE12000-082000-092000-09
NCT00835406Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.COMPLETEDPHASE12000-062000-072000-07
NCT00203034Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCOMPLETEDPHASE32000-052003-012003-01
NCT00864760A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE11999-061999-061999-06
NCT00865631A Limited Food Effect Study of Gabapentin 800 mg TabletsCOMPLETEDPHASE11999-061999-061999-06
NCT00864058A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting ConditionsCOMPLETEDPHASE11998-011998-011998-01
NCT00864305A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting ConditionsCOMPLETEDPHASE11997-121998-011998-01
NCT00203060Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCOMPLETEDPHASE31997-072000-072000-07
NCT00203021Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and EffectivenessCOMPLETEDPHASE41994-03-262018-02-282018-02-28